The board of directors at Mediar Therapeutics has a wide range of experience in the medical and pharmaceutical industries, as well as academic research. This experience includes working as a Research Therapeutic Area Head at Ferring Pharmaceuticals, Assistant Molecular Biologist at Massachusetts General Hospital, and Assistant Professor of Surgery at Harvard Medical School. The board also has experience as a Partner at SV Health Investors and as a Board Member at Triplet Therapeutics, Lodo Therapeutics Corporation, and TRex Bio. Furthermore, the members of the board have education histories in Biology, Cell and Molecular from Saint Louis University and Biophysics, Biochemistry from Columbia University in the City of New York.
View all